Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Wellness Times.
Press releases published on April 24, 2025

Tarsus to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025
IRVINE, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that it will host a live webcast at 1:30 p.m. PT / 4:30 p.m. ET on Thursday, May 1, 2025, to report its first quarter 2025 financial results and …

Colibri Laser & Beauty Expands Clinical Services and Professional Development Efforts in Response to Industry Growth
TORONTO, ONTARIO, CANADA, April 24, 2025 /EINPresswire.com/ -- Responding to increased demand for non-invasive cosmetic treatments and skilled practitioners, Colibri Laser …

Insta-Soothe Under Review: The Healthy Flow Joint Support Minty Oil Relief Cream That Works
New York City, April 24, 2025 (GLOBE NEWSWIRE) -- In This Article, You'll Discover: The everyday causes of joint and muscle discomfort and why it affects all age groups Why do many conventional pain relief options fall short of long-term joint support The …

HCI Group Declares Quarterly Cash Dividend
TAMPA, Fla., April 24, 2025 (GLOBE NEWSWIRE) -- The board of directors of HCI Group, Inc. (NYSE: HCI) has declared a regular quarterly cash dividend in the amount of 40 cents per common share. The dividend is scheduled to be paid June 20, 2025 to …

CVRx to Report First Quarter 2025 Financial and Operating Results and Host Conference Call on May 8, 2025
MINNEAPOLIS, April 24, 2025 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company, today announced that it plans to release first quarter 2025 financial and operating results after market close on Thursday, May 8 …

Clarus Sets First Quarter 2025 Conference Call for Thursday, May 8, 2025, at 5:00 p.m. ET
SALT LAKE CITY, April 24, 2025 (GLOBE NEWSWIRE) -- Clarus Corporation (NASDAQ: CLAR) (“Clarus” and/or the “Company”), a global company focused on the outdoor enthusiast markets, will hold a conference call on Thursday, May 8, 2025, at 5:00 pm ET to discuss …

Rapid Micro Biosystems to Announce First Quarter 2025 Financial Results on May 9, 2025
LEXINGTON, Mass., April 24, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and …

NurExone to Showcase Breakthrough in Facial Nerve Regeneration at ISEV 2025
TORONTO and HAIFA, Israel, April 24, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”) a preclinical-stage biotechnology company pioneering exosome-based therapies for central nervous system …

Brain Savior Under Review: Mind Boosting Memory Loss Support Formula for Mindful Wellness
New York City, April 24, 2025 (GLOBE NEWSWIRE) -- In This Article, You'll Discover: Why brain fog, mental fatigue, and memory lapses are becoming increasingly common in today's fast-paced world How Brain Savior by Mindful Wellness offers stimulant-free, …

GENFIT Reports Full-Year 2024 Financial Results and Provides Corporate Update
Cash and cash equivalents totaled €81.8 million as of December 31, 2024. In addition, completion in early 2025 of: (i) a non-dilutive royalty financing agreement for up to €185 million including a first installment of €130 million and (ii) the debt …

GENFIT : Résultats financiers annuels 2024 et point sur les activités de la Société
Trésorerie et équivalents de trésorerie s’élevant à 81,8 millions d’euros au 31 décembre 2024. En outre, conclusion, en début d’année (i) d’un accord de royalty financing non dilutif d'un montant maximum de 185 millions d'euros comprenant un versement …

Cytek Biosciences to Report First Quarter 2025 Financial Results on May 8, 2025
FREMONT, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), today announced it will report financial results for the first quarter 2025 after market close on Thursday, May 8, 2025. The …

Sight Sciences to Report First Quarter 2025 Financial Results on May 8, 2025
MENLO PARK, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”), an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to …

Beyond Air Granted U.S. Patent Covering Treatment of NTM Infections Using gaseous Nitric Oxide (gNO)
GARDEN CITY, N.Y., April 24, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial-stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve the lives …

Treace to Report First Quarter 2025 Financial Results on May 8, 2025
PONTE VEDRA, Fla., April 24, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities …

Peloton Interactive, Inc. Announces Date of Third Quarter 2025 Earnings Release and Conference Call
NEW YORK, April 24, 2025 (GLOBE NEWSWIRE) -- Peloton Interactive, Inc. (NASDAQ: PTON) will release its third quarter 2025 financial results before the U.S. stock market opens on Thursday, May 8, 2025. The company will host a conference call and live audio …

FluidForm Bio™ Announces Advance in Bioprinted Tissue Therapies with Landmark Publication in Science Advances
WALTHAM, Mass., April 24, 2025 (GLOBE NEWSWIRE) -- FluidForm Bio™, a leader in cell therapies for chronic diseases such as type 1 diabetes, today announced the publication of a groundbreaking paper in the journal Science Advances detailing the development …

Seer to Report First Quarter 2025 Financial Results on May 13, 2025
REDWOOD CITY, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that it will report financial results for the first quarter 2025 …

Merit Medical Reports First Quarter 2025 Results and Updates Full-Year Guidance
First Quarter Highlights† Reported revenue of $355.4 million, up 9.8% Constant currency revenue* and constant currency revenue, organic* up 10.9% and up 6.0%, respectively GAAP operating margin of 11.5%, compared to 11.1% in prior year period Non-GAAP …

Catheter Precision to Attend and Participate in the 46th Heart Rhythm Society
Fort Mill, S.C., April 24, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market announced their …